Cloning & Mutagenesis Market to be dominated by Gene Induced Immunotherapy type through 2028
Increasing prevalence of chronic and
genetic diseases is expected to drive the growth of global cloning &
mutagenesis in the forecast period, 2024-2028.
According to TechSci Research report,
“Cloning & Mutagenesis Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028F”, the global cloning & mutagenesis
market is anticipated to grow at an impressive rate in the forecast period, 2024-2028.
This can be ascribed to the increasing prevalence of chronic and genetic
diseases like cancer and HIV, along with growing healthcare expenditure across
the globe. Additionally, growing investment on research and development for the
treatment of genetic disorders and other diseases, especially in the developed
countries in the North America and Europe, is expected to create lucrative
opportunities for the market growth in the coming years. Besides, increasing
demand for laboratory automation and more awareness of preventive healthcare is
further expected to support the market growth. Similarly, the increasing demand
for personalized medicine adoption of cloning and mutagenesis tools have
increased such as PCR is expected to boost the market growth during the
forecasted period. Also, the growing focuses on protein engineering for drug
development is expected to drive the growth of the market. Additionally,
growing demand for genetically modified products such as crops is anticipated
to drive the growth of the market over the years.
However, high cost of cloning and
mutagenesis kits can create affordability issues thereby slowing down the
growth of global cloning & mutagenesis market in the forecast period.
Similarly, high risks and complications associated with treatments, may hamper
the cloning & mutagenesis market growth during the forecast period. Also,
lack of accuracy in methods of cloning and mutagenesis, along with ethical
issues surrounding the terminology in emerging countries, can further restrict
the growth of global cloning & mutagenesis market. Also, lack of
infrastructure and instruments may hamper the growth of the market during the
forecasted years.
Browse over XX market data Figures
spread through XX
Pages and an in-depth TOC on "Cloning & Mutagenesis Market"
The global cloning & mutagenesis market can be segmented by gene type, by
product type, by technique, by application, by end user and by region.
Based on product type, the global
cloning & mutagenesis market can be divided into Cloning Kits v/s
Mutagenesis Kits. The Mutagenesis Kit segment dominated the market in 2022 and
is expected to continue maintaining its dominance throughout the forecast
period. This can be ascribed to increasing demand for early detection of
chronic diseases such as cancer and HIV for better treatment and diagnosis
across the region and helping immunocompromised patients. Also, growing
applications of mutagenesis kits in biomedical research and adoption of this
advanced kits in research and development can boost the market growth during
the forecasted years.
Based on Application, the market can be
segmented into Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research,
Others. The Vaccine Research segment is expected to dominate during the
forecast period on account of increasing demand for personalized medicine for
the treatment of chronic diseases like HIV and Cancer.
Major companies operating in global cloning & mutagenesis market are:
- Agilent Technologies, Inc.
- Eurofins Scientific SE
- Sartorius AG
- Collecta, Inc.
- Codex DNA Inc.
- Lonza Group AG
- Charles River Laboratories
International, Inc.
- TransGene Biotech Co. Ltd.
- Takara Bio, Inc.
- Thermo Fisher Scientific Inc.
For instance, in November 2021, Genes2Me launched a
molecular product range, which includes cloning, next-generation technology,
and enzyme technology among other product categories. The product range
contains the Fantom High-Fidelity PCR DNA polymerase, which can significantly
improve PCR test sensitivity, making it a feasible cornerstone for cloning
technology.
For instance, in October 2022, GM mustard was
approved by Genetic Engineering Appraisal Committee GEAC for commercial
release. This initiative is expected to catalyze crop improvement to meet
nutritional needs.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“The North America
is expected to dominate in the global cloning & mutagenesis market on account of increasing investment by
government organizations for the development of stem cell and cancer research across
the region. Furthermore, increasing number of biotechnology companies in the
region, along with increasing prevalence of chronic diseases, are further
contributing to the demand for cloning and mutagenesis market. Besides, increasing
demand for adopting personalized medicine services and developing healthcare
systems for the treatment of different type of chronic diseases like breast
cancer, prostate cancer, blood cancer in the region, are further expected to
create lucrative opportunities for the market growth” said Mr. Karan Chechi,
Research Director with TechSci Research, a research based global management
consulting firm.
“Cloning
& Mutagenesis Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented
By Gene Type (Standard v/s Complex), By Product Type (Cloning Kits v/s
Mutagenesis Kits), By Technique (Topo PCR Cloning, Blunt End Cloning, Seamless
Cloning, Site-Directed Mutagenesis, Others), By Application (Gene Synthesis,
Gene Expression, Gene Therapy, Vaccine Research, Others), By End User
(Pharmaceutical & Biotechnology Companies, Academic & Research
Institutions, Others), By
Region and Competition”, has evaluated
the future growth potential of global cloning & mutagenesis market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in global cloning & mutagenesis market.
Contact
Mr. Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]m
Website: https://www.techsciresearch.com